HD LifeSciences Receives 510(k) Clearance for Hive™ ALIF Standalone System

BOSTON, MA, May 12th, 2020 –

HD LifeSciences has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Hive™ ALIF Standalone Lumbar Interbody Fusion System. The patented implant system features a modular anterior portion that allows surgeon choice and flexibility in using integrated zero-profile fixation or anterior plating. The implant also features a patent-pending mechanism that allows the surgeon to adjust the footprint of the device pre-implantation to better match patient anatomy.

“This system is the next step forward for HD’s Hive™ implants,” says David Rattigan, Vice President of Sales for HD LifeSciences. “We are proud to offer this differentiated implant technology to our surgeon users.”

The Hive™ ALIF Standalone System will offer surgeons a variety of implant configurations, with multiple width, height, depth, and lordotic choices to accommodate patient needs.

About HD LifeSciences

HD Lifesciences is transforming orthopedic care with our Hive™ Soft Titanium® technology. The Hive™ lattice with NanoHive® Surface Technology provides ideal elastic modulus, diagnostic imaging, and osteogenic properties. Founded with a mission to improve surgical methods and devices, HD LifeSciences brings together science and engineering to improve patient care.

HiveTM ALIF Standalone System Press Release/DCO 20-011

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button